Skip to main content
Idrees Mian, MD, Oncology, Upper Marlboro, MD

IdreesMianMD

Oncology Upper Marlboro, MD

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Hematologist / Oncologist

Dr. Mian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mian's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at Houstonn/a, General Internal Medicine Fellowship, 2015 - 2016
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2015
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2012, MD

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2016 - 2025
  • VA State Medical License
    VA State Medical License 2020 - 2024
  • DC State Medical License
    DC State Medical License 2020 - 2024
  • TX State Medical License
    TX State Medical License 2015 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.  
    Yezaz Ghouri , Idrees Mian, Julie Rowe, Journal of carcinogenesis, 2017
  • Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma  
    Idrees Mian MD Denái R. Milton MS Nina Shah MD Yago Nieto MD, PhD Uday R. Popat MD Partow Kebriaei MD Simrit Parmar MD Betul Oran MD Jatin J. Shah MD Elisabet ..., Cancer, 9/2016
  • Milk Alkali Syndrome: A Consequence of Addiction to Betel Nut Chewing  
    Neel Shah, Lavanya Sendos, Idrees Mian, AACE Clinical Case Reports, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genes
    Raffit Hassan, Betsy Morrow, Tom Walsh, Ming K. Lee, James Gao, Idrees Mian, Javed Khan, American Society of Clinical Oncology, Chicago, 6/2018
  • Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab.
    Idrees Mian , MD; Ming Yang; Hui Zhao; Mohsin Shah, MD; Adi Diab, MD; Vickie Shannon, MD; Aneesha Patel MD; Rodabia Amaria, MD; Sharon Giordano, MD; Maria Suarez-Almoz..., American Society of Clinical Oncology, Chicago, 6/2016
  • Tick-borne illness causing Hemophagocytic lymphohistiocytosis
    Sarah Kazzaz , Idrees Mian, Sameer Baba, Wafi Momin, Harinder Juneja, Texas Chapter of ACP Meeting, Houston TX, 1/1/2015
  • Join now to see all

Lectures

  • Effect of Timing and Duration of Maintenance Lenalidomide in Myeloma Patients after Autologous Stem Cell Transplantations 
    San Francisco CA - 1/1/2014
  • Vision For All: The Establishment Of A Vision Screening Program For Primary Schools In The Northern Himalayan Region Of Kashmir 
    Denver, CO - 1/1/2011